Article Text

Download PDFPDF
QRISK2 validation by ethnic group
  1. Julia Hippisley-Cox1,
  2. Carol Coupland1,
  3. John Robson2,
  4. Peter Brindle3
  1. 1Division of Primary Care, University Park, Nottingham, UK
  2. 2Queen Mary's University, UK
  3. 3Avon Primary Care Research Collaborative, Bristol Clinical Commissioning Group, Bristol, UK
  1. Correspondence to Professor Julia Hippisley-Cox, Division of Primary Care, 13th floor, Tower Building, University Park, Nottingham NG2 7RD, UK; Julia.hippisley-cox{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

To the Editor: Tillin et al recently reported a cohort study1 comparing the performance of QRISK2 and Framingham in the Southall and Brent cohort in London. We have a number of comments on the study and the interpretation of results.

  1. Number of events. The main problem with the paper is that numbers are very small and given the resulting wide CIs the authors have overstated their findings. There is no information on how many patients had the outcome in the different ethnic groups, but there were only 78 events in …

View Full Text


  • Contributors All authors contributed to this letter.

  • Competing interests None.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Linked Articles